Evidence map›Paper›PMID 29059176›Full record

ArticlePLoS neglected tropical diseases2017

Candidate genes-based investigation of susceptibility to Human African Trypanosomiasis in Côte d'Ivoire.

Bernardin Ahouty, Mathurin Koffi, Hamidou Ilboudo, Gustave Simo, Enock Matovu, Julius Mulindwa, Christiane Hertz-Fowler, Bruno Bucheton, Issa Sidibé, Vincent Jamonneau and 4 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 5 countries.

Bernardin AhoutyLaboratoire de Génétique, Félix Houphouët Boigny University, Abidjan, Côte d'Ivoire.
Mathurin KoffiUnité de Recherche en Génétique et Epidémiology Moléculaire, Jean Lorougnon Guédé University, Daloa, Côte d'Ivoire.
Hamidou IlboudoUnité Maladies à Vecteurs et Biodiversité, Centre International de Recherche-Développement sur l'Elevage en zone Subhumide, Bobo-Dioulasso, Burkina Faso.
Gustave SimoDepartment of Biochemistry, University of Dchang, Dchang, Cameroon.
Enock MatovuSchool of Veterinary Medicine, Makerere University, Kampala, Uganda.
Julius MulindwaSchool of Veterinary Medicine, Makerere University, Kampala, Uganda.
Christiane Hertz-FowlerCentre for Genomic Research, University of Liverpool, Liverpool, United Kingdom.
Bruno BuchetonUnité Mixte de Recherche 177 IRD-CIRAD, Institut de Recherche pour le Développement, Montpellier, France.
Issa SidibéUnité Maladies à Vecteurs et Biodiversité, Centre International de Recherche-Développement sur l'Elevage en zone Subhumide, Bobo-Dioulasso, Burkina Faso.
Vincent JamonneauUnité Mixte de Recherche 177 IRD-CIRAD, Institut de Recherche pour le Développement, Montpellier, France.
Annette MacLeodWellcome Center for Molecular Parasitology, University of Glasgow, Glasgow, United Kingdom.
Harry NoyesCentre for Genomic Research, University of Liverpool, Liverpool, United Kingdom.
Simon-Pierre N'GuettaLaboratoire de Génétique, Félix Houphouët Boigny University, Abidjan, Côte d'Ivoire.
TrypanoGEN Research Group as members of The H3Africa Consortium
Centre international de recherche-développement sur l'elevage en zone subhumide · BFMakerere University · UGUniversité Félix Houphouët-Boigny · CIUniversity of Liverpool · GBCentre de Coopération Internationale en Recherche Agronomique pour le Développement · FRInstitut de Recherche pour le Développement · FRUniversité Jean Lorougnon Guédé · CIWellcome Centre for Molecular Parasitology · GB

Funding

Medical Research Council G0900753Medical Research Council MR/K002279/1Wellcome Trust
6 · The paper itself

Abstract

Human African Trypanosomiasis (HAT) or sleeping sickness is a Neglected Tropical Disease. Long regarded as an invariably fatal disease, there is increasing evidence that infection by T. b. gambiense can result in a wide range of clinical outcomes, including latent infections, which are long lasting infections with no parasites detectable by microscopy. The determinants of this clinical diversity are not well understood but could be due in part to parasite or host genetic diversity in multiple genes, or their interactions. A candidate gene association study was conducted in Côte d'Ivoire using a case-control design which included a total of 233 subjects (100 active HAT cases, 100 controls and 33 latent infections). All three possible pairwise comparisons between the three phenotypes were tested using 96 SNPs in16 candidate genes (IL1, IL4, IL4R, IL6, IL8, IL10, IL12, IL12R, TNFA, INFG, MIF, APOL1, HPR, CFH, HLA-A and HLA-G). Data from 77 SNPs passed quality control. There were suggestive associations at three loci in IL6 and TNFA in the comparison between active cases and controls, one SNP in each of APOL1, MIF and IL6 in the comparison between latent infections and active cases and seven SNP in IL4, HLA-G and TNFA between latent infections and controls. No associations remained significant after Bonferroni correction, but the Benjamini Hochberg false discovery rate test indicated that there were strong probabilities that at least some of the associations were genuine. The excess of associations with latent infections despite the small number of samples available suggests that these subjects form a distinct genetic cluster different from active HAT cases and controls, although no clustering by phenotype was observed by principle component analysis. This underlines the complexity of the interactions existing between host genetic polymorphisms and parasite diversity.

Indexed as

Genetic Association StudiesGenetic Predisposition to DiseaseAdolescentAdultAgedAged, 80 and overApolipoprotein L1ApolipoproteinsCase-Control StudiesChildCote d'IvoireFemaleHumansInterleukin-4Interleukin-6Intramolecular OxidoreductasesAPOL1 protein, humanApolipoprotein L1ApolipoproteinsIL4 protein, humanIL6 protein, humanInterleukin-4Interleukin-6Intramolecular OxidoreductasesLipoproteins, HDLMacrophage Migration-Inhibitory FactorsMIF protein, humanTumor Necrosis Factor-alpha

Identifiers

PMID29059176
PMCPMC5695625
OpenAlexW2950604450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.